Home
TFFP
TFFP News

Latest TFF Pharmaceuticals Inc. (TFFP) News on July 26, 2024

TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities

GlobeNewswire

a month ago

TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities

TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus Inhalation Powder (TFF TAC) Clinical Program for the Prevention of Lung Transplant Rejection

GlobeNewswire

a month ago

TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus Inhalation Powder (TFF TAC) Clinical Program for the Prevention of Lung Transplant Rejection

MT Newswires

2 months ago

TFF Pharmaceuticals, Leidos to Advance Biodefense Countermeasures Into Preclinical Testing

TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing

GlobeNewswire

2 months ago

TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing

MT Newswires

2 months ago

TFF Pharmaceuticals Advances Influenza Vaccine Candidates Into Preclinical Testing

TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing

GlobeNewswire

2 months ago

TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing

TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection

GlobeNewswire

2 months ago

TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection

TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Tops Revenue Estimates

Zacks

2 months ago

TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Tops Revenue Estimates

TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

GlobeNewswire

2 months ago

TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering

GlobeNewswire

3 months ago

TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering

MT Newswires

3 months ago

TFF Pharmaceuticals Prices $4.8 Million Public Offering; Shares Down Pre-Bell

TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering

GlobeNewswire

3 months ago

TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering

TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting

GlobeNewswire

3 months ago

TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting

TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions

GlobeNewswire

3 months ago

TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions

TFF Pharmaceuticals Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

4 months ago

TFF Pharmaceuticals Full Year 2023 Earnings: Misses Expectations

TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

4 months ago

TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs

GlobeNewswire

4 months ago

TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs

TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting

GlobeNewswire

4 months ago

TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting

TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

4 months ago

TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

4 months ago

TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

TFF Pharmaceuticals Announces Update on Clinical Programs

GlobeNewswire

4 months ago

TFF Pharmaceuticals Announces Update on Clinical Programs

TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024

GlobeNewswire

4 months ago

TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024

Gold Resource Corporation Announces Preliminary Fourth Quarter and Year-End Results

Business Wire

6 months ago

Gold Resource Corporation Announces Preliminary Fourth Quarter and Year-End Results

Is GigaCloud Technology Inc. (GCT) Outperforming Other Business Services Stocks This Year?

Zacks

6 months ago

Is GigaCloud Technology Inc. (GCT) Outperforming Other Business Services Stocks This Year?

Here's Why Momentum in EuroDry (EDRY) Should Keep going

Zacks

6 months ago

Here's Why Momentum in EuroDry (EDRY) Should Keep going

Space Race Speculation: 3 Stocks Soaring in the New Frontier

InvestorPlace

6 months ago

Space Race Speculation: 3 Stocks Soaring in the New Frontier

Associated Press Finance

6 months ago

Bassett: Fiscal Q4 Earnings Snapshot

Bassett Announces Fiscal Fourth Quarter Results

GlobeNewswire

6 months ago

Bassett Announces Fiscal Fourth Quarter Results

FAT Brands (FAT) Reports Solid Unit Developments in 2023

Zacks

6 months ago

FAT Brands (FAT) Reports Solid Unit Developments in 2023

MoneyHero Group Preannounces Record Breaking Year-Over-Year Growth, Outshining Competitors

GlobeNewswire

6 months ago

MoneyHero Group Preannounces Record Breaking Year-Over-Year Growth, Outshining Competitors

TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference

GlobeNewswire

6 months ago

TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference

Alliance Entertainment to Host Fiscal Second Quarter 2024 Results Conference Call on Thursday, February 8, 2024 at 4:30 p.m. Eastern Time

GlobeNewswire

6 months ago

Alliance Entertainment to Host Fiscal Second Quarter 2024 Results Conference Call on Thursday, February 8, 2024 at 4:30 p.m. Eastern Time

Nauticus Robotics Secures Additional Funding, Appoints New Executive Management, Improves Operations and Cost Structures, and Engages Strategic Advisor

PR Newswire

7 months ago

Nauticus Robotics Secures Additional Funding, Appoints New Executive Management, Improves Operations and Cost Structures, and Engages Strategic Advisor

TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting

GlobeNewswire

7 months ago

TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting

Via Renewables, Inc. Enters into Agreement for all of Its Class A Common Stock to be Acquired at $11.00 Per Share in Cash

ACCESSWIRE

7 months ago

Via Renewables, Inc. Enters into Agreement for all of Its Class A Common Stock to be Acquired at $11.00 Per Share in Cash

Here's Why Electrameccanica Vehicles (NASDAQ:SOLO) Must Use Its Cash Wisely

Simply Wall St.

7 months ago

Here's Why Electrameccanica Vehicles (NASDAQ:SOLO) Must Use Its Cash Wisely

CMCT Declares Common Stock Dividend

Business Wire

7 months ago

CMCT Declares Common Stock Dividend

TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TAC

GlobeNewswire

7 months ago

TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TAC

TFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TAC

GlobeNewswire

7 months ago

TFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TAC

MDV or ESS: Which Is the Better Value Stock Right Now?

Zacks

7 months ago

MDV or ESS: Which Is the Better Value Stock Right Now?

TFF Pharmaceuticals Announces Reverse Stock Split

GlobeNewswire

7 months ago

TFF Pharmaceuticals Announces Reverse Stock Split

TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors

GlobeNewswire

7 months ago

TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors

New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT

GlobeNewswire

8 months ago

New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT

Vertex Energy Meets Renewable Fuel Standard Revised Annual Compliance Report Filing Deadline of December 1, 2023, for Calendar Year 2022

Business Wire

8 months ago

Vertex Energy Meets Renewable Fuel Standard Revised Annual Compliance Report Filing Deadline of December 1, 2023, for Calendar Year 2022

Annovis Bio Appoints Andrew Walsh as Vice President Finance

GlobeNewswire

8 months ago

Annovis Bio Appoints Andrew Walsh as Vice President Finance

TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors

GlobeNewswire

8 months ago

TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors

TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors

GlobeNewswire

8 months ago

TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors

Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant

ACCESSWIRE

8 months ago

Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant

7 Penny Stocks With Low Floats and High Short Interest

InvestorPlace

8 months ago

7 Penny Stocks With Low Floats and High Short Interest

eHealth, Inc. Announces Senior Leadership Changes and Reaffirms Full Year Fiscal 2023 Guidance

PR Newswire

8 months ago

eHealth, Inc. Announces Senior Leadership Changes and Reaffirms Full Year Fiscal 2023 Guidance

Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire

8 months ago

Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Business Wire

8 months ago

Intevac Announces Participation in 12th Annual NYC Summit

Willamette Valley Vineyards Posts results for Q3 2023

PR Newswire

8 months ago

Willamette Valley Vineyards Posts results for Q3 2023

Professional Diversity Network, Inc. Announces Financial Results for the Quarter Ended September 30, 2023

GlobeNewswire

8 months ago

Professional Diversity Network, Inc. Announces Financial Results for the Quarter Ended September 30, 2023

Associated Press Finance

8 months ago

Reading International: Q3 Earnings Snapshot

Reading International Reports Third Quarter 2023 Results

GlobeNewswire

8 months ago

Reading International Reports Third Quarter 2023 Results

Air T, Inc. Reports Second Quarter Fiscal 2024 Results

ACCESSWIRE

8 months ago

Air T, Inc. Reports Second Quarter Fiscal 2024 Results

U.S. Energy Corp. Reports Financial and Operating Results for Third Quarter 2023

GlobeNewswire

8 months ago

U.S. Energy Corp. Reports Financial and Operating Results for Third Quarter 2023

ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript

PLBY Group Reports Third Quarter 2023 Financial Results

GlobeNewswire

9 months ago

PLBY Group Reports Third Quarter 2023 Financial Results

Hyperfine, Inc. Reports Third Quarter 2023 Financial Results

GlobeNewswire

9 months ago

Hyperfine, Inc. Reports Third Quarter 2023 Financial Results

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

GlobeNewswire

9 months ago

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Fossil Group Inc Earnings Call

Intevac (NASDAQ:IVAC) investors are sitting on a loss of 40% if they invested three years ago

Simply Wall St.

9 months ago

Intevac (NASDAQ:IVAC) investors are sitting on a loss of 40% if they invested three years ago

Associated Press Finance

9 months ago

Fossil Group: Q3 Earnings Snapshot

Fossil Group, Inc. Reports Third Quarter 2023 Financial Results

GlobeNewswire

9 months ago

Fossil Group, Inc. Reports Third Quarter 2023 Financial Results

InspireMD, Inc. (NASDAQ:NSPR) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

InspireMD, Inc. (NASDAQ:NSPR) Q3 2023 Earnings Call Transcript

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

GlobeNewswire

9 months ago

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Beasley Broadcast Group Inc Earnings Call

Beasley Broadcast Group (BBGI) Surpasses Q3 Earnings Estimates

Zacks

9 months ago

Beasley Broadcast Group (BBGI) Surpasses Q3 Earnings Estimates

Share on Social Networks: